Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
Not Applicable
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Device: Microwave ablation
- Registration Number
- NCT06086002
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
To compare safety and efficacy of microwave ablation with simultaneous ablation using two antennas versus overlapping ablation with single antenna for small hepatocellular carcinoma
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Child-Pugh Class A or B
- chronic hepatitis B or chronic hepatitis C or liver cirrhosis
- presence of hepatocellular carcinoma (HCC) confirmed by pathology or imaging studies including contrast enhanced computed tomography (CT) or magnetic resonance imaging (MRI) according to Liver Imaging Reporting and Data System (LI-RADS) v2018
- single lesion less than or equal to 3 cm, or up to 3 lesions, each greater than less than or equal to 3 cm at the time of locoregional treatment
Exclusion Criteria
- number of recurrent HCCs, equal or more than 3
- largest recurrent HCC size over 3 cm
- presence of vascular invasion by HCC
- diffuse infiltrative type HCC
- HCCs located less than 5 mm from central bile duct or large portal vein or large hepatic vein
- platelet count less than 40,000 per mm3 or International Normalized Ratio (INR) prolongation over 50%
- presence of extrahepatic metastasis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Simultaneous ablation with two antennas Microwave ablation - Overlapping ablation with single antenna Microwave ablation -
- Primary Outcome Measures
Name Time Method Technical success Immediately after ablation Evaluate technical success defined as complete ablation of the index tumor with safety margin, equal or larger than 5 mm on immediate CT.
Technique efficacy 1 month after ablation Evaluate technical success defined as complete ablation of the index tumor on 1 month follow-up CT.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of